SEVERE ACUTE EXACERBATIONS OF HEPATITIS B, PATIENTS CO-INFECTED WITH HIV AND HBV, and LACTIC ACIDOSIS AND HEPATOMEGALY
See full prescribing information for complete boxed warning.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Baraclude (Bristol-Myers Squibb)
- INDICATIONS: Chronic hepatitis B virus infection
- CLASS: Antiviral, Guanosine nucleoside analog
- HALF-LIFE: ~24 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/02/2023
